Product Code: TIPRE00015468
The vaccines market was valued at US$ 39,128.3 million in 2019 and is projected to reach US$ 64,538.4 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027.The major driving factors are rising prevalence of infectious diseases, growing focus on immunization programs, and increasing support for vaccine development are expected to boost the market growth over the years. However, soaring prices of the vaccines and complexity and cost of vaccine manufacturing are likely to pose a negative impact on the market growth.On the other hand, robust pipeline of vaccines is likely to have a positive impact on the growth of the global vaccines market in the coming years.In the current era, there are increasing concerns of spread of infectious diseases with the changing environment. These emerging infectious diseases are a burden on public health but have also an impact on global economies. The new diseases such as HIV, hepatitis, dengue have attracted a huge concern for the government of the respective countries. There is also resurgence of diseases which seemed to be under control such as malaria, cholera and many more. According to the Centers for Disease control and Prevention in 2015, 16.8 million people in the US visited hospitals due to infectious and parasitic diseases. In Africa, chronic viral hepatitis affects around 70 million Africans (60 million with Hepatitis B and 10 million with Hepatitis C). The disease impacts the most important part of the African population i.e. youths and earning African population which are causing tremendous rise in financial debts incurred for the treatment of advanced liver diseases and emotional distress.Thus the growing global prevalence of infectious diseases are expected to encourage the leading market players for the development of new and effective drugs and vaccines.
The vaccines market by technology is segmented into Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines. In 2019, the conjugate vaccines segment held a largest market share in the vaccines market , By Technology. This segment is also expected to dominate the market in 2027 as they are the most effective forms of immunization, used to prevent diseases in both infants and adults. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 6.3% during the forecast period, 2020 to 2027 owing to the increasing demand for drugs to treat the disease.
The global vaccines market on the patient type is segmented into pediatric patients and adult patients. In 2018, the pediatric segment held a largest market share in the vaccines market , by patient type. This segment is also expected to dominate the market in 2027 as external immunization is necessary for the new borns. Moreover, vaccines have helped the children in staying healthy and been successful to save millions of lives for more than 50 years.
Some of the major primary and secondary sources for vaccines included in the report are World Health Organization (WHO), European Medical Agency (EMA), Advisory Committee on Immunization Practices(ACIP), China Food and Drug Administration (CFDA), Council of Scientific and Industrial Research (CSIR), French Scientific Research Centre (FSRC), and others.
Reasons to Buy:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table Of Contents
1. Introduction
- 1.1 Scope Of The Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Vaccines Market - By Technology
- 1.3.2 Global Vaccines Market - By Disease Indication
- 1.3.3 Global Vaccines Market - By Route of Administration
- 1.3.4 Global Vaccines Market - By Patient Type
- 1.3.5 Global Vaccines Market - By Geography
2. Vaccines Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Global Vaccines Market - Market Landscape
- 4.1 Overview
- 4.2 Pest Analysis
- 4.2.1 North America - PEST Analysis
- 4.2.2 Europe- PEST Analysis
- 4.2.3 Asia Pacific- PEST Analysis
- 4.2.4 Middle East & Africa- PEST Analysis
- 4.2.5 South and Central America - PEST Analysis
- 4.3 Expert Opinions
5. Global Vaccines Market - Key Market Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Rising Prevalence of Infectious Diseases
- 5.1.2 Growing Focus on Immunization Programs
- 5.1.3 Increasing Support for Vaccine Development
- 5.2 Key Market Restraints
- 5.2.1 The Complexity And Cost of Vaccine Manufacturing
- 5.2.2 Soaring Costs of Vaccines
- 5.3 Key Market Opportunities
- 5.3.1 Robust Pipeline of Vaccines
- 5.4 Future Trends
- 5.4.1 New Vaccine Delivery Systems
- 5.5 Impact Analysis
6. Vaccines Market - Global Analysis
- 6.1 Global Vaccines Market Revenue Forecasts And Analysis
- 6.2 Global Vaccines Market, By Geography - Forecasts And Analysis
- 6.3 Performance Of Key Players
- 6.3.1 GlaxoSmithKline plc
- 6.3.2 Sanofi
7. Vaccines Market - Technology
- 7.1 Overview
- 7.2 Vaccines Market Share, Technology, 2019 And 2027 (%)
- 7.3 Recombinant Vaccinesinant Vaccines
- 7.3.1 Overview
- 7.3.2 Recombinant Vaccinesinant Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
- 7.4 Conjugate Vaccines
- 7.4.1 Overview
- 7.4.2 Conjugate Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
- 7.5 Live Attenuated Vaccines Attenuated Vaccines
- 7.5.1 Overview
- 7.5.2 Live Attenuated Vaccines Attenuated Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
- 7.6 Inactivated and Subunit Vaccines Vaccines
- 7.6.1 Overview
- 7.6.2 Inactivated and Subunit Vaccines Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
- 7.7 Toxoid Vaccines Vaccines
- 7.7.1 Overview
- 7.7.2 Toxoid Vaccines Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
8. Vaccines Market- Disease Indication
- 8.1 Overview
- 8.2 Disease Indication Market Revenue And Forecasts Analysis (Us$ Mn)
- 8.3 Dtp (Diphtheria, Tetanus, And Pertussis)
- 8.3.1 Overview
- 8.3.2 DTP (Diphtheria, Tetanus, And Pertussis): Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
- 8.4 Influenza
- 8.4.1 Overview
- 8.4.2 Influenza: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
- 8.5 Dengue
- 8.5.1 Overview
- 8.5.2 Dengue: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
- 8.6 Cytomegalovirus (CMV)
- 8.6.1 Overview
- 8.6.2 Cytomegalovirus (CMV): Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
- 8.7 Hepatitis
- 8.7.1 Overview
- 8.7.2 Hepatitis: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
- 8.7.3 Hepatitis A
- 8.7.3.1 Overview
- 8.7.3.2 Hepatitis A: Hepatitis Market - Revenue and Forecast to 2027 (US$ Million)
- 8.7.4 Hepatitis B
- 8.7.4.1 Overview
- 8.7.4.2 Hepatitis B: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
- 8.8 Respiratory Syncytial Virus (Rsv)
- 8.8.1 Overview
- 8.8.2 Respiratory Syncytial Virus (RSV): Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
- 8.9 Other Diseases
- 8.9.1 Overview
- 8.9.2 Other Diseases: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
9. Vaccines Market- Route Of Administration
- 9.1 Overview
- 9.2 Route Of Administration Market Revenue And Forecasts Analysis (Us$ Mn)
- 9.3 Oral
- 9.3.1 Overview
- 9.3.2 Oral: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
- 9.4 Injectable
- 9.4.1 Overview
- 9.4.2 Injectable: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
- 9.5 Other Routes Of Administrations
- 9.5.1 Overview
- 9.5.2 Other Routes of Administration; Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10. Vaccines Market- Patient Type
- 10.1 Overview
- 10.2 Patient Type Market Revenue And Forecasts Analysis (Us$ Mn)
- 10.3 Paediatric
- 10.3.1 Overview
- 10.3.2 Pediatric: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
- 10.4 Adults Market
- 10.4.1 Overview
- 10.4.2 Adults: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
11. Vaccines Market- Geographical Analysis
- 11.1 North America: Vaccines Market
- 11.1.1 Overview
- 11.1.2 North America: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.1.3 North America: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.1.4 North America: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.1.4.1 North America: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.1.5 North America: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.1.6 North America: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.1.7 North America: Vaccines Market, By Country, 2019 & 2027 (%)
- 11.1.8 US Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.1.8.1 US: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.1.8.2 US: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.1.8.2.1 US: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.1.8.3 US: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.1.8.4 US: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.1.9 Canada Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.1.9.1 Canada: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.1.9.2 Canada: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.1.9.3 Canada: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.1.9.3.1 Canada: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.1.9.4 Canada: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.1.9.5 Canada: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.1.10 Mexico Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.1.10.1 Mexico: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.1.10.2 Mexico: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.1.10.3 Mexico: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.1.10.3.1 Mexico: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.1.10.4 Mexico: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.1.10.5 Mexico: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.2 Europe: Vaccines Market
- 11.2.1 Overview
- 11.2.2 Europe: Vaccines Market Revenue, by Country (2019) (US$ Mn)
- 11.2.3 Europe: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.2.4 Europe: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.2.5 Europe: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.2.5.1 Europe: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.2.6 Europe: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.2.7 Europe: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.2.8 Europe: Vaccines Market, By Country, 2019 & 2027 (%)
- 11.2.9 Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.2.9.1 Germany: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.2.9.2 Germany: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.2.9.3 Germany: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.2.9.3.1 Germany: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.2.9.4 Germany: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.2.9.5 Germany: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.2.10 UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.2.10.1 UK: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.2.10.2 UK: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.2.10.3 UK: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.2.10.3.1 UK: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.2.10.4 UK: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.2.10.5 UK: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.2.11 France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.2.11.1 France: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.2.11.2 France: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.2.11.3 France: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.2.11.3.1 France: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.2.11.4 France: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.2.11.5 France: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.2.12 Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.2.12.1 Italy: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.2.12.2 Italy: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.2.12.3 Italy: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.2.12.3.1 Italy: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.2.12.4 Italy: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.2.12.5 Italy: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.2.13 Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.2.13.1 Spain: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.2.13.2 Spain: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.2.13.3 Spain: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.2.13.3.1 Spain: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.2.13.4 Spain: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.2.13.5 Spain: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.3 Asia Pacific Vaccines Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.3.3 Asia Pacific: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.3.4 Asia Pacific: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.3.4.1 Asia Pacific: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.3.5 Asia Pacific: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.3.6 Asia Pacific: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.3.7 Asia Pacific: Vaccines Market, By Country, 2018 & 2027 (%)
- 11.3.8 China Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.3.8.1 China: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.3.8.2 China: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.3.8.3 China: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.3.8.3.1 China: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.3.8.4 China: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.3.8.5 China: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.3.9 Japan Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.3.9.1 Japan: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.3.9.2 Japan: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.3.9.3 Japan: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.3.9.3.1 Japan: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.3.9.4 Japan: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.3.9.5 Japan: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.3.10 India Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.3.10.1 India: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.3.10.2 India: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.3.10.3 India: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.3.10.3.1 India: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.3.10.4 India: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.3.10.5 India: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.3.11 Australia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.3.11.1 Australia: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.3.11.2 Australia: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.3.11.3 Australia: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.3.11.3.1 Australia: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.3.11.4 Australia: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.3.11.5 Australia: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.3.12 South Korea Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.3.12.1 South Korea: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.3.12.2 South Korea: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.3.12.3 South Korea: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.3.12.3.1 South Korea: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.3.12.4 South Korea: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.3.12.5 South Korea: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.4 Middle East & Africa Vaccines Market
- 11.4.1 Middle East And Africa: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.4.2 Middle East and Africa: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.4.3 Middle East and Africa: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.4.3.1 Middle East and Africa: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.4.4 Middle East and Africa: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.4.5 Middle East and Africa: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.4.6 Middle East & Africa: Vaccines Market, By Country, 2019 & 2027 (%)
- 11.4.7 UAE Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.4.7.1 UAE: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.4.7.2 UAE: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.4.7.3 UAE: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.4.7.3.1 UAE: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.4.7.4 UAE: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.4.7.5 UAE: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.4.8 Saudi Arabia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.4.8.1 Saudi Arabia: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.4.8.2 Saudi Arabia: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.4.8.3 Saudi Arabia: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.4.8.3.1 Saudi Arabia: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.4.8.4 Saudi Arabia: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.4.8.5 Saudi Arabia: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.4.9 South Africa Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.4.9.1 South Africa: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.4.9.2 South Africa: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.4.9.3 South Africa: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.4.9.3.1 South Africa: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.4.9.4 South Africa: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.4.9.5 South Africa: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.5 South And Central America Vaccines Market
- 11.5.1 Overview
- 11.5.2 South and Central America: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.5.3 South and Central America: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.5.4 South and Central America: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.5.4.1 South and Central America: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.5.5 South and Central America: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.5.6 South and Central America: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.5.7 South and Central America: Vaccines Market, by Country, 2019 and 2027 (%)
- 11.5.8 Brazil Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.5.8.1 Brazil: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.5.8.2 Brazil: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.5.8.3 Brazil: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.5.8.3.1 Brazil: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.5.8.4 Brazil: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.5.8.5 Brazil: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
- 11.5.9 Argentina Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- 11.5.9.1 Argentina: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
- 11.5.9.2 Argentina: Vaccines Market, By Technology, 2018-2027 (USD Million)
- 11.5.9.3 Argentina: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
- 11.5.9.3.1 Argentina: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
- 11.5.9.4 Argentina: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
- 11.5.9.5 Argentina: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
12. Impact Of Covid-19 Pandemic On Global Vaccines Market
- 12.1 North America: Impact assessment of COVID-19 Pandemic
- 12.2 Europe: Impact assessment of COVID-19 Pandemic
- 12.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
- 12.4 Rest of World: Impact assessment of COVID-19 Pandemic
13. Vaccines Market - Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies Done By The Companies In The Market, (%)
- 13.3 Organic Developments
- 13.4 Inorganic Developments
14. Vaccines Market -Key Company Profiles
- 14.1 Pfizer Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Financial Overview
- 14.1.4 Product Portfolio
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Glaxosmithkline Plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Financial Overview
- 14.2.4 Product Portfolio
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Merck & Co., Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Financial Overview
- 14.3.4 Product Portfolio
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Sanofi
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Financial Information
- 14.4.4 Product Portfolio
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Johnson & Johnson Services, Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Financial Overview
- 14.5.4 Product Portfolio
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Panacea Biotec Limited
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Financial Information
- 14.6.4 Product Portfolio
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Astellas Pharma Inc.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Financial Overview
- 14.7.4 Product Portfolio
- 14.7.5 Swot Analysis
- 14.7.6 Key Developments
- 14.8 Novavax, Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Financial Information
- 14.8.4 Product Pipeline
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Vbi Vaccines Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Financial Information
- 14.9.4 Product Portfolio
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 Bavarian Nordic
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Financial Information
- 14.10.4 Product Pipeline
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary Of Terms
比較リスト
